In Brief: McNeil's Nasalcrom
This article was originally published in The Tan Sheet
Executive Summary
McNeil's Nasalcrom: OTC account to be handled by Saatchi & Saatchi Healthcare Connection, the ad agency announces Oct. 25. The assignment follows FDA advisory committee recommendation for OTC use ("The Tan Sheet" Oct. 14, p. 1). "Established earlier this to capitalize on the growing consumer healthcare marketing category," Healthcare Connection plans to begin Nasalcrom campaign in 1997...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning